obesity
Conditions
Interventions
There will be 12 weeks of intervention and two groups formed randomly: the group that will receive the herbal treatment and the placebo group. 20 participants will be allocated to the placebo group an
and capsules containing 300mg of starch for the placebo group, an inert constituent in drug formulations. In order for the capsules to look similar and hide the internal constituent, colored capsules
E02.190.755
Sponsors
Universidade Federal de São Carlos
Universidade Federal de São Carlos
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Women; age between 45 and 65 years; in post-menopause; overweight; or obesity
Exclusion criteria
Exclusion criteria: Participants who do not sign the Free Informed Consent form; women who have received hormone therapy in the last 6 months; surgery-induced menopause; with untreated hypothyroidism; presence of kidney or liver diseases; any type of cancer; and with inflammatory or infectious disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A 5% to 10% reduction in body weight | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of climacteric symptoms, classified and quantified by the Kupperman Index | — |
Countries
Brazil
Contacts
Public ContactGerson Rodrigues
Universidade Federal de São Carlos
Outcome results
None listed